We advocate for compounding pharmacies and facilities on a range of state and federal issues affecting patient access to compounded medications. We represent pharmacists and technicians in both traditional 503A compounding pharmacies and 503B outsourcing facilities, as well as prescribers, patients, educators, and suppliers. We’re 5,000 members strong and growing.
.png?width=908&height=106&name=Layer_1%20(1).png)
This week, APC took a firm stand against government misinformation by sending a strongly worded letter to the FDA challenging its recent statement on ...
Introducing access to a new benefit for APC members, large and small: medical, dental, vision, and life insurance coverage.
This past weekend, the APC Owner Summit proved once again why it’s the premier event for compounding pharmacy owners.
If you're passionate about compounding pharmacy, isn't it time you considered taking your dedication to the next level?
As of March 10, 2025, 503A pharmacies are no longer permitted to prepare copies of tirzepatide injections; 503B outsourcing facilities have until ...
.png?width=410&height=320&name=image-container%20(1).png)
.png?width=410&height=320&name=image-container%20(2).png)
.png?width=411&height=320&name=image-container%20(3).png)
.png?width=410&height=320&name=image-container%20(4).png)
.png)
.png?width=17&height=16&name=folder%20(1).png){kind=small}
%20Pharma-GS.png)